TAL1 GENE DELETIONS AND TAL1 PROTEIN EXPRESSION IN SPORADIC MELANOMA

被引:2
|
作者
CHETTY, R
CERRONI, L
PULFORD, K
GIATROMANOLAKI, A
BIDDOLPH, S
KAKLAMANIS, L
GATTER, K
机构
[1] University Department of Cellular Science, University of Oxford, Oxford
[2] Department of Dermatology, University of Graz, Graz
[3] Department of Paediatric Pathology, John Radcliffe Hospital, Oxford
关键词
CHROMOSOME; 1P32; MELANOMA; TAL1;
D O I
10.1097/00008390-199508000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies on cytogenetic abnormalities and cell lines have implicated chromosome 1p32 as being important in the pathogenesis of melanoma, Genetic linkage studies have also mapped a melanoma-susceptibility locus to chromosome Ip, The gene TAL1 is present on chromosome 1p32, and deletions within it are the commonest chromosomal abnormality in T-acute lymphoblastic leukaemia (T-ALL), A melanoma cell line harbouring a 1p32 deletion involving the TALI gene and the presence of TAL1 protein in developing mouse melanocytes led us to investigate whether TAL1 deletions and/or TAL1 protein expression occur in sporadic melanomas, DNA extracted from 32 fresh melanomas was amplified by standard polymerase chain reaction for the four common deletions of the TAL1 gene that occur in T-ALL. In addition, frozen and paraffin-embedded sections of these melanomas were stained with monoclonal antibodies that detect full-length and truncated TAL1 protein. The results of the study show that deletions of TAL1 do not occur in melanoma. Indeed, full and truncated TAL1 protein also could not be detected immunohistochemically in the paraffin-embedded and frozen sections of the melanomas. We conclude that the TAL1 gene and its protein are probably not directly involved in the oncogenesis of melanomas.
引用
收藏
页码:251 / 254
页数:4
相关论文
共 50 条
  • [1] Tal1 binding to centromeric satellite DNA: A new role for Tal1 in transcription repression.
    Wen, J
    Noguchi, T
    Shigematsu, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 367 - 367
  • [2] Tal1 transgenic expression in B-lymphocytes
    Efanov, Alexey A.
    Palamarchuk, Alexey
    Zanesi, Nicola
    Aqeilan, Rami
    Maximov, Vadim
    Santanam, Urmila
    Hagan, John
    Croce, Carlo M.
    Pekarsky, Yuri
    CANCER RESEARCH, 2006, 66 (08)
  • [3] Expression of the TAL1 protein in AML: Correlation with morphology, immunophenotype and prognosis
    Bourquelot, PM
    Meyer, V
    Delabesse, E
    Bernard, M
    Pulford, K
    Garand, R
    Imbert, M
    Valensi, F
    Varet, B
    Flandrin, G
    Macintyre, EA
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 817 - 817
  • [4] The Role of TAL1 in Hematopoiesis and Leukemogenesis
    Vagapova, E. R.
    Spirin, P. V.
    Lebedev, T. D.
    Prassolov, V. S.
    ACTA NATURAE, 2018, 10 (01): : 15 - 23
  • [5] Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis
    Li, Y.
    Deng, C.
    Hu, X.
    Patel, B.
    Fu, X.
    Qiu, Y.
    Brand, M.
    Zhao, K.
    Huang, S.
    ONCOGENE, 2012, 31 (48) : 5007 - 5018
  • [6] Targets of the Tal1 Transcription Factor in Erythrocytes E2 UBIQUITIN CONJUGASE REGULATION BY Tal1
    Lausen, Joern
    Pless, Ole
    Leonard, Fransisca
    Kuvardina, Olga N.
    Koch, Benjamin
    Leutz, Achim
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (08) : 5338 - 5346
  • [7] Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis
    Y Li
    C Deng
    X Hu
    B Patel
    X Fu
    Y Qiu
    M Brand
    K Zhao
    S Huang
    Oncogene, 2012, 31 : 5007 - 5018
  • [8] Another piece for the SCl/TAL1 puzzle
    Crooks, Gay M.
    BLOOD, 2006, 108 (09) : 2886 - 2886
  • [9] SCL/TAL1 regulates erythropoietin receptor expression.
    Rogers, Heather M.
    Yu, Xiaobing
    Noguchi, Constance Tom
    BLOOD, 2006, 108 (11) : 352A - 352A
  • [10] Tal1 transgenic expression reveals absence of B lymphocytes
    Palamarchuk, Alexey
    Zanesi, Nicola
    Aqeilan, Rami I.
    Efanov, Alexey
    Maximov, Vadim
    Santanam, Urmila
    Hagan, John P.
    Croce, Carlo M.
    Pekarsky, Yuri
    CANCER RESEARCH, 2006, 66 (12) : 6014 - 6017